Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.091 | 0.02 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |